Why in Brazil, where allergy-free products are mixed, don't they combine all the extracts into a single bottle?

Reading time: 16 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Why in Brazil, where allergy-free products are mixed, don't they combine all the extracts into a single bottle?

Clinical Summary and Overview

To clearly understand the clinical aspects involved in Why in Brazil, people without allergies don't mix? This is an essential step for those seeking diagnostic certainty, lasting symptom relief, and prevention of complications. In the daily practice of Allergology and Clinical Immunology, questions related to... "Why in Brazil, where allergies aren't handled, don't all the extracts mix into a single bottle?" Allergy-free conditions are common among patients and their families. The goal of this page in the Brazil Allergy-Free Encyclopedia is to present a complete, accessible, and evidence-based medical analysis, detailing causes, immunological mechanisms, and safe practices.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Why in Brazil, where allergy-free products are mixed, don't they combine all the extracts into a single bottle?

Why don't allergenic extracts mix in a single bottle in the Brazil Without Allergies Project?

A common question in Allergy and Immunology clinics concerns the preparation and administration of allergy vaccines (allergen-specific immunotherapy). Brazil Without Allergies ProjectWe rigorously follow scientific and legal guidelines to ensure maximum efficacy and safety for our patients, which includes the clinical decision not to mix different allergenic extracts in the same bottle. This conduct is based on two essential pillars: the biochemical interaction between the substances and the legislation in force in the country.

Scientific factors: efficacy and action of proteases

From a clinical and pharmacological standpoint, mixing extracts of different natures—such as mites, animal dander, fungi, and pollen—can seriously compromise the potency of the treatment. Certain allergens, especially pollen, contain high concentrations of enzymes called proteases. When mixed with other allergenic proteins in the same vial, these proteases can degrade and denature the other components, even completely neutralizing the therapeutic action of the vaccine.

As a direct consequence of this degradation, the patient—often a child—would receive an ineffective product, undergoing repeated applications without the expected immunological benefit. To avoid this damage to the body's response, the specialists of the Brazil Without Allergies Project use the extracts in isolation, ensuring that each substance maintains its integrity and full therapeutic potential.

Legal certainty and the regulatory framework of Anvisa

Beyond the technical aspects, there is a fundamental legal aspect that governs medical practice and the compounding of medications in Brazil. Health legislation and guidelines from competent authorities determine that the mixing of different active ingredients or extracts to create a new pharmacological compound is the exclusive responsibility of the pharmaceutical industry or compounding pharmacies duly authorized and licensed by Anvisa (Brazilian Health Regulatory Agency) for this specific purpose.

Medical practice regarding immunotherapies involves safe dilution and individualization of concentration—leading the patient from the induction phase to the maintenance phase—using the parent substance provided by the manufacturer. Mixing individual extracts in a doctor's office without proper compatibility registration would be equivalent to manufacturing a new drug without the approval of the regulatory agency, which violates health safety standards.

Adopting protocols based on scientific evidence and respecting Brazilian laws protects the patient against ineffective therapies and guarantees the complete reliability of the treatment. This content is for educational and informational purposes only and does not, under any circumstances, replace individualized medical consultation and evaluation with a specialist in Allergy and Immunology.

Developments in Evidence-Based Medicine: Drug Hypersensitivity Reactions

According to the international consensus guidelines on drug allergy (EAACI/AAAAI/WAO), the hypersensitivity reactions to medications These reactions are divided into immediate reactions (generally occurring within the first hour to 6 hours after exposure, mediated by specific IgE or by direct activation of mast cells/cyclooxygenase-1 pathway in non-steroidal anti-inflammatory drugs, manifesting as urticaria, angioedema, bronchospasm, or anaphylaxis) and delayed reactions (mediated by specific T lymphocytes, ranging from maculopapular rashes to severe drug-induced skin reactions such as DRESS syndrome, Stevens-Johnson syndrome, and toxic epidermal necrolysis). In cross-intolerance to NSAIDs and in Aspirin-Exacerbated Respiratory Disease (AED)Inhibition of the COX-1 enzyme diverts arachidonic acid metabolism toward excessive synthesis of cysteinyl leukotrienesDefining safe alternative medications and developing challenge or desensitization protocols requires an in-person evaluation at a specialized Allergy and Immunology service.

💎 Diamond Plan — Knowing exactly which medications you react to provides lifelong peace of mind. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Immune Reactions to Insect Bites and Prevention of Crises

Difference between Exaggerated Local Reaction, Strophulus, and Anaphylaxis

Reactions triggered by arthropods are clinically divided between hypersensitivity to the saliva of hematophagous insects (such as mosquitoes, black flies, and fleas, which cause papular urticaria in childhood) and systemic allergy to the venom of hymenoptera (bees, wasps, and fire ants). While salivary antigens usually generate persistent pruritic papules and a risk of secondary bacterial infection from scratching, venom injected by a stinger can trigger massive mast cell degranulation mediated by IgE antibodies, requiring evaluation of baseline serum tryptase and an emergency action plan.

Etiological Diagnosis and Specific Desensitization

In addition to physical barriers (protective screens, light-colored clothing, and age-appropriate repellents such as icaridin), long-term clinical control relies on... treatment for mosquito bite allergy allied to allergy vaccineAllergen-specific immunotherapy promotes progressive immune tolerance by stimulating IgG4 class blocking antibodies and drastically reducing both recurrent skin lesions and the risk of severe reactions upon re-exposure.

Inflammation of the Respiratory Mucosa, House Mites, and Local Complications

Under the medical concept of a 'single airway', uncontrolled inflammation of the nasal cavities and paranasal sinuses directly impacts the ears (Eustachian tube dysfunction), eyes (rhinoconjunctivitis), sleep quality, and bronchi. In specific subgroups, such as Aspirin-Exacerbated Respiratory Disease (AERD), recurrent nasal polyposis, asthma, and intolerance to COX-1 inhibitor anti-inflammatory drugs are also present, requiring specialized diagnosis to restore the sense of smell and respiratory patency.

Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication

Drug hypersensitivity reactions encompass distinct immunological and pharmacological mechanisms: from immediate reactions (up to one to six hours after dosing, manifested by urticaria, labial or palpebral angioedema, bronchospasm, and anaphylaxis, common with COX-1 inhibitor analgesics and beta-lactams) to delayed drug eruptions mediated by T cells, such as maculopapular rashes and DRESS syndrome — a systemic condition that arises weeks after the start of anticonvulsants, sulfones, or allopurinol, presenting with fever, lymphadenomegaly, eosinophilia, and the need for immediate discontinuation under hospital supervision.

Importance of Differential Diagnosis and Detailed Medical History

In the specialty of Allergy and Immunology, two patients with seemingly similar symptoms involving allergies in Brazil may present completely distinct pathophysiological mechanisms. For this reason, a thorough clinical history—investigating the chronology of crises, home and work environment, family history of atopy, use of concomitant medications, and dietary habits—serves as an indispensable compass for correctly interpreting laboratory tests (such as total and specific IgE levels) and functional tests. A single laboratory result never replaces in-person clinical judgment or specialized telemedicine, preventing misdiagnosis and unnecessary treatments.

Environmental Prevention, Therapeutic Adherence, and Continuous Monitoring

Long-term success in managing allergic and immunological conditions depends directly on the alliance between targeted medical treatment and daily educational measures. Maintaining well-ventilated environments free from accumulated household dust, preserving the physiological hydration of mucous membranes and the skin barrier, strictly adhering to the schedules and technique for using prescribed preventive medications, and conducting periodic check-ups allow for the stabilization of subclinical inflammation before it progresses to acute exacerbations.

Clinical Safety Criteria and Warning Signs in Allergology

Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.

Impact on Quality of Life, Sleep, and Systemic Well-being

Beyond the direct physical manifestations, uncontrolled conditions linked to allergies in Brazil profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, feeds back into the immune inflammatory response. Therefore, establishing a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being.

Frequently Asked Questions in Clinical Practice

Mechanisms of Food Allergy, Accurate Diagnosis and Nutritional Management: The immune system associated with the gastrointestinal mucosa normally functions by maintaining oral tolerance to thousands of dietary proteins. When this immune barrier is broken—influenced by genetic predisposition, dysbiosis of the intestinal microbiota, or immaturity of secretory IgA in childhood—intact protein fractions sensitize mast cells and basophils. Therefore, a single positive blood test reflects only biological sensitization and should always be correlated with the clinical history and, when necessary, with a supervised oral food challenge in a medical setting.

Immunology of the Digestive Mucosa: Gut-Airway Axis and Differential Diagnosis: Immune-mediated disorders of the gastrointestinal tract—including eosinophilic esophagitis, celiac disease, and non-celiac gluten sensitivity—share alterations in the integrity of the tight junctions of the digestive epithelium. In eosinophilic esophagitis, frequently associated with rhinitis, asthma, and atopic dermatitis, eosinophil infiltration of the esophageal wall causes dysphagia, food impaction, and symptoms that mimic gastroesophageal reflux refractory to proton pump inhibitors.

Skin Barrier Health, Immune Inflammation, and Pruritus Control: In eczematous dermatitis and cases of chronic pruritus, differentiating constitutional atopy from allergic contact dermatitis (a type IV delayed hypersensitivity reaction mediated by T lymphocytes sensitized to metals, cosmetic preservatives, fragrances, resins, or rubber) is essential. Repeated exposure to the sensitizing agent maintains active skin inflammation even with the use of anti-inflammatory ointments, requiring precise identification of the triggering factor.

Immunology of Cutaneous Autoimmune Diseases and Integrated Care: Unlike purely IgE-mediated dermatoses, psoriasis and related autoimmune conditions involve the activation of plasmacytoid dendritic cells, interferon-gamma production, and sustained stimulation of the interleukin-23/interleukin-17 (IL-23/IL-17) and TNF-alpha axis. This signaling accelerates the epidermal keratinocyte renewal cycle several times over, resulting in well-defined erythematous-desquamative plaques and, in some patients, associated joint inflammation. Infections, mechanical or chemical trauma to the skin (Koebner phenomenon), dry winter weather, and emotional stress act as important amplifiers of the inflammatory response.

Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management: When isolated recurrent angioedema occurs without surrounding pruritic plaques, immunological reasoning must distinguish histaminergic conditions from those mediated by bradykinin—including hereditary or acquired angioedema due to functional or quantitative deficiency of C1-esterase inhibitor (C1-INH) and reactions induced by angiotensin-converting enzyme (ACE) inhibitor antihypertensive drugs. This differentiation is vital because bradykinin-related angioedema does not respond to conventional antihistamines or corticosteroids.

Control of Bronchial Inflammation, Lung Function, and Prevention of Remodeling: Bronchial asthma and allergic bronchitis are chronic inflammatory diseases of the lower airways, characterized by bronchial hyperreactivity, mucosal edema, mucus hypersecretion, and variable obstruction to expiratory airflow. When eosinophilic or allergic inflammation (type 2) remains uncontrolled over the years—or when the patient uses only short-term bronchodilators without treating the underlying inflammation—thickening of the basement membrane and hypertrophy of the bronchial smooth muscle occur, a process known as bronchial remodeling.

Unified Airway: Management of Rhinitis, Rhinosinusitis, and Nasal Hypersensitivity: Under the medical concept of a 'single airway', uncontrolled inflammation of the nasal cavities and paranasal sinuses directly impacts the ears (Eustachian tube dysfunction), eyes (rhinoconjunctivitis), sleep quality, and bronchi. In specific subgroups, such as Aspirin-Exacerbated Respiratory Disease (AERD), recurrent nasal polyposis, asthma, and intolerance to COX-1 inhibitor anti-inflammatory drugs are also present, requiring specialized diagnosis to restore the sense of smell and respiratory patency.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up through telemedicine and easy access to immunotherapy treatment. Knowing exactly which medications you react to provides lifelong peace of mind.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

In summary, the appropriate approach to Why in Brazil, people without allergies don't mix? This requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoid self-medication and investigate the root cause of symptoms—relying on specialized resources and reliable guidance such as... allergy vaccine When clinically relevant, it is the safest way to manage crises, prevent complications, and ensure sustainable quality of life.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: